<DOC>
	<DOCNO>NCT01610479</DOCNO>
	<brief_summary>This phase 1 study TAS-114 combination S-1 patient advance solid tumor .</brief_summary>
	<brief_title>A Study TAS-114 Combination With S-1 Patients With Advanced Solid Tumors</brief_title>
	<detailed_description>This phase 1 , open-label , non-randomized , dose-escalating safety , tolerability , pharmacokinetic study TAS-114 combination S-1 patient advance solid tumor .</detailed_description>
	<criteria>Life expectancy least 3 month Histological cytological documentation advance solid tumor ECOG Performance Status â‰¤ 1 ( ECOG : Eastern Cooperative Oncology Group ) Adequate bone marrow , liver renal function Women childbearing potential men must agree use adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>